{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T11:11:02Z","timestamp":1782040262262,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejrad.2025.112033","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T20:50:57Z","timestamp":1741812657000},"page":"112033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Fast (&lt; 30\u00a0min) \u201cAll-in-One\u201d whole-body MRI for TNM staging in high-risk prostate cancer (PCa): Feasibility and comparison to 68Ga-Prostate Specific Membrane Antigen (PSMA)-PET\/CT"],"prefix":"10.1016","volume":"186","author":[{"given":"Sandy Van","family":"Nieuwenhove","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Lhommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Pasoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien Van","family":"Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Michoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Triqueneaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Tombal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3568-3254","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric E.","family":"Lecouvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2025.112033_b0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/bs.acr.2024.04.002","article-title":"Prostate MRI for the detection of clinically significant prostate cancer: update and future directions","volume":"161","author":"Trecarten","year":"2024","journal-title":"Adv. Cancer Res."},{"issue":"10231","key":"10.1016\/j.ejrad.2025.112033_b0010","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejrad.2025.112033_b0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 update. part i: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur. Urol."},{"key":"#cr-split#-10.1016\/j.ejrad.2025.112033_b0020.1","doi-asserted-by":"crossref","unstructured":"E. Lopci, G. Lughezzani, V. Fasulo, M. Lazzeri, Re: Stefano Fanti, Alberto Briganti, Louise Emmett, et al. EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography\/Computed Tomography in Patients with Prostate Cancer and with Respect to [(177)Lu]Lu-PSMA Radioligand Therapy. Eur Urol Oncol. 2022;5:530-6: Extended Use of PSMA PET\/CT in Candidates for Focal Therapy, Eur Urol Oncol 5","DOI":"10.1016\/j.euo.2022.06.006"},{"key":"#cr-split#-10.1016\/j.ejrad.2025.112033_b0020.2","doi-asserted-by":"crossref","unstructured":"(5) (2022) 601-60210.1016\/j.euo.2022.06.006.","DOI":"10.1088\/1475-7516\/2022\/06\/006"},{"issue":"17","key":"10.1016\/j.ejrad.2025.112033_b0025","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.19.02757","article-title":"Optimum imaging strategies for advanced prostate cancer: ASCO guideline","volume":"38","author":"Trabulsi","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ejrad.2025.112033_b0030","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/pros.22764","article-title":"One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): toward an upfront simplified \u201call-in-one\u201d imaging approach?","volume":"74","author":"Pasoglou","year":"2014","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.ejrad.2025.112033_b0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.juro.2017.02.071","article-title":"Combined whole body and multiparametric prostate magnetic resonance imaging as a 1-step approach to the simultaneous assessment of local recurrence and metastatic disease after radical prostatectomy","volume":"198","author":"Robertson","year":"2017","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.ejrad.2025.112033_b0040","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1007\/s00330-019-06515-y","article-title":"Shortening the acquisition time of whole-body MRI: 3D T1 gradient echo Dixon vs fast spin echo for metastatic screening in prostate cancer","volume":"30","author":"Lecouvet","year":"2020","journal-title":"Eur. Radiol."},{"issue":"3","key":"10.1016\/j.ejrad.2025.112033_b0045","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/jmri.27485","article-title":"Whole-body magnetic resonance imaging for prostate cancer assessment: current status and future directions","volume":"55","author":"Van Nieuwenhove","year":"2022","journal-title":"J. Magn. Reson Imag."},{"issue":"3","key":"10.1016\/j.ejrad.2025.112033_b0050","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur. Urol."},{"issue":"7","key":"10.1016\/j.ejrad.2025.112033_b0055","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00261-024-04332-6","article-title":"Biparametric versus multiparametric MRI for the detection of clinically significant prostate cancer in a diverse, multiethnic population","volume":"49","author":"Abramson","year":"2024","journal-title":"Abdominal Radiol. (New York)"},{"issue":"3","key":"10.1016\/j.ejrad.2025.112033_b0060","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231383","article-title":"Comparison of positive predictive values of biparametric MRI and multiparametric MRI-directed transrectal US-guided targeted prostate biopsy","volume":"311","author":"Schieda","year":"2024","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.ejrad.2025.112033_b0065","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.23.30496","article-title":"Multiparametric versus biparametric prostate MRI: comparison of NPV for clinically significant prostate cancer","volume":"222","author":"Birosh","year":"2024","journal-title":"AJR Am. J. Roentgenol."},{"issue":"3","key":"10.1016\/j.ejrad.2025.112033_b0070","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41391-020-00298-w","article-title":"A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk","volume":"24","author":"Bass","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"3","key":"10.1016\/j.ejrad.2025.112033_b0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/bju.14538","article-title":"Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer","volume":"123","author":"Van Nieuwenhove","year":"2019","journal-title":"BJU Int."},{"issue":"2","key":"10.1016\/j.ejrad.2025.112033_b0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. part II-2024 update: treatment of relapsing and metastatic prostate cancer","volume":"86","author":"Tilki","year":"2024","journal-title":"Eur. Urol."},{"issue":"6","key":"10.1016\/j.ejrad.2025.112033_b0085","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1007\/s00330-023-10436-2","article-title":"Head-to-head comparison of prostate-specific membrane antigen PET and multiparametric MRI in the diagnosis of pretreatment patients with prostate cancer: a meta-analysis","volume":"34","author":"Ma","year":"2024","journal-title":"Eur. Radiol."},{"issue":"10","key":"10.1016\/j.ejrad.2025.112033_b0090","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1007\/s00330-019-06085-z","article-title":"MRI for prostate cancer: can computed high b-value DWI replace native acquisitions?","volume":"29","author":"Jendoubi","year":"2019","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2025.112033_b0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clinimag.2017.09.004","article-title":"Apparent diffusion coefficient in the analysis of prostate cancer: determination of optimal b-value pair to differentiate normal from malignant tissue","volume":"47","author":"Adubeiro","year":"2018","journal-title":"Clin. Imag."},{"issue":"3","key":"10.1016\/j.ejrad.2025.112033_b0100","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00261-014-0225-7","article-title":"T2-weighted imaging of the prostate: Impact of the BLADE technique on image quality and tumor assessment","volume":"40","author":"Rosenkrantz","year":"2015","journal-title":"Abdom. Imag."},{"issue":"1","key":"10.1016\/j.ejrad.2025.112033_b0105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eururo.2016.05.033","article-title":"METastasis reporting and data system for prostate cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer","volume":"71","author":"Padhani","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejrad.2025.112033_b0110","doi-asserted-by":"crossref","unstructured":"S.P. Rowe, K.J. Pienta, M.G. Pomper, M.A. Gorin, Proposal for a Structured Reporting System for Prostate-Specific Membrane Antigen-Targeted PET Imaging: PSMA-RADS Version 1.0, Journal of nuclear medicine: official publication, Society of Nuclear Medicine 59(3) (2018) 479-48510.2967\/jnumed.117.195255.","DOI":"10.2967\/jnumed.117.195255"},{"issue":"3","key":"10.1016\/j.ejrad.2025.112033_b0115","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1148\/radiol.2018181278","article-title":"A grading system for the assessment of risk of extraprostatic extension of prostate cancer at multiparametric MRI","volume":"290","author":"Mehralivand","year":"2019","journal-title":"Radiology"},{"issue":"15","key":"10.1016\/j.ejrad.2025.112033_b0120","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/pros.24420","article-title":"Comparison of 68Ga-PSMA PET\/CT and mp-MRI in regard to local staging for prostate cancer with histopathological results: a retrospective study","volume":"82","author":"Ucar","year":"2022","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.ejrad.2025.112033_b0125","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.eururo.2017.10.027","article-title":"PSMA-RADS Version 1.0: A step towards standardizing the interpretation and reporting of PSMA-targeted PET imaging studies","volume":"73","author":"Rowe","year":"2018","journal-title":"Eur. Urol."},{"issue":"Pt 1","key":"10.1016\/j.ejrad.2025.112033_b0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1348\/000711006X126600","article-title":"Computing inter-rater reliability and its variance in the presence of high agreement","volume":"61","author":"Gwet","year":"2008","journal-title":"Br. J. Math. Stat. Psychol."},{"issue":"66","key":"10.1016\/j.ejrad.2025.112033_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23660","article-title":"Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies","volume":"23","author":"Taylor","year":"2019","journal-title":"Health Technol. Assess. (Winchester, England)"},{"issue":"8","key":"10.1016\/j.ejrad.2025.112033_b0140","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41585-022-00618-w","article-title":"The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer","volume":"19","author":"Wang","year":"2022","journal-title":"Nat. Rev. Urol."},{"issue":"10","key":"10.1016\/j.ejrad.2025.112033_b0145","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S1470-2045(18)30571-0","article-title":"Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group","volume":"19","author":"Lecouvet","year":"2018","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.ejrad.2025.112033_b0150","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.euo.2018.11.009","article-title":"Who benefits from multiparametric magnetic resonance imaging after suspicion of prostate cancer?","volume":"2","author":"Morote","year":"2019","journal-title":"Eur. Urol. Oncol."},{"issue":"6","key":"10.1016\/j.ejrad.2025.112033_b0155","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","article-title":"The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study","volume":"80","author":"Emmett","year":"2021","journal-title":"Eur. Urol."},{"issue":"12","key":"10.1016\/j.ejrad.2025.112033_b0160","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.2967\/jnumed.117.207696","article-title":"One-stop-shop whole-body (68)Ga-PSMA-11 PET\/MRI compared with clinical nomograms for preoperative T and N staging of high-risk prostate cancer","volume":"59","author":"Thalgott","year":"2018","journal-title":"J. Nucl. Med.: Offi. Publ., Soc. Nucl. Med."},{"key":"10.1016\/j.ejrad.2025.112033_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.111274","article-title":"(68)Ga-prostate specific membrane antigen-11 PET\/CT versus multiparametric MRI in the detection of primary prostate cancer: a systematic review and head-to-head comparative meta-analysis","volume":"170","author":"Ren","year":"2024","journal-title":"Eur. J. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2025.112033_b0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40644-017-0133-5","article-title":"(68)Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer","volume":"17","author":"Iravani","year":"2017","journal-title":"Cancer Imag."},{"issue":"2","key":"10.1016\/j.ejrad.2025.112033_b0175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/RCT.0000000000001116","article-title":"Comparison of MRI PSMA PET\/CT, and fusion PSMA PET\/MRI for detection of clinically significant prostate cancer","volume":"45","author":"Arslan","year":"2021","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"4","key":"10.1016\/j.ejrad.2025.112033_b0180","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s13139-017-0476-7","article-title":"(68)Ga-PSMA PET\/CT imaging predicting intraprostatic tumor extent extracapsular extension and seminal vesicle invasion prior to radical prostatectomy in patients with prostate cancer","volume":"51","author":"von Klot","year":"2017","journal-title":"Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejrad.2025.112033_b0185","article-title":"Added value of [18F]PSMA-1007 PET\/CT and PET\/MRI in patients with biochemically recurrent prostate cancer: impact on detection rates and clinical management","author":"Abrahamsen","year":"2024","journal-title":"J. Magn. Reson. Imag."},{"issue":"21","key":"10.1016\/j.ejrad.2025.112033_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215286","article-title":"Comparison of (68)Ga-prostate specific membrane antigen (PSMA) positron emission tomography computed tomography (PET-CT) and whole-body magnetic resonance imaging (WB-MRI) with diffusion sequences (DWI) in the staging of advanced prostate cancer","volume":"13","author":"Van Damme","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejrad.2025.112033_b0195","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1200\/EDBK_159241","article-title":"Approach to oligometastatic prostate cancer","volume":"35","author":"Bernard","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"5","key":"10.1016\/j.ejrad.2025.112033_b0200","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.euo.2021.02.003","article-title":"Positron emission tomography and whole-body magnetic resonance imaging for metastasis-directed therapy in hormone-sensitive oligometastatic prostate cancer after primary radical treatment: a systematic review","volume":"4","author":"Farolfi","year":"2021","journal-title":"Eur. Urol. Oncol."},{"issue":"8","key":"10.1016\/j.ejrad.2025.112033_b0205","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/MNM.0000000000001219","article-title":"Interobserver and intraobserver agreement on prostate-specific membrane antigen PET\/CT images according to the miTNM and PSMA-RADS criteria","volume":"41","author":"Demirci","year":"2020","journal-title":"Nucl. Med. Commun."},{"issue":"3","key":"10.1016\/j.ejrad.2025.112033_b0210","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1148\/radiol.2016152542","article-title":"Interobserver reproducibility of the PI-RADS version 2 lexicon: a multicenter study of six experienced prostate radiologists","volume":"280","author":"Rosenkrantz","year":"2016","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ejrad.2025.112033_b0215","doi-asserted-by":"crossref","DOI":"10.1186\/s40644-020-00350-x","article-title":"Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between readers of different expertise levels","volume":"20","author":"Pricolo","year":"2020","journal-title":"Cancer Imag."},{"issue":"3","key":"10.1016\/j.ejrad.2025.112033_b0220","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.230427","article-title":"Deep learning super-resolution reconstruction for fast and motion-robust T2-weighted Prostate MRI","volume":"308","author":"Bischoff","year":"2023","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.ejrad.2025.112033_b0225","doi-asserted-by":"crossref","first-page":"7985","DOI":"10.1007\/s00330-024-10883-5","article-title":"Image quality of whole-body diffusion MR images comparing deep-learning accelerated and conventional sequences","volume":"34","author":"Ponsiglione","year":"2024","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2025.112033_b0230","article-title":"Fast MRI reconstruction using deep learning-based compressed sensing: a systematic review","author":"Safari","year":"2024","journal-title":"ArXiv"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25001196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25001196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:01:32Z","timestamp":1778752892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X25001196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":47,"alternative-id":["S0720048X25001196"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.112033","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fast (< 30\u00a0min) \u201cAll-in-One\u201d whole-body MRI for TNM staging in high-risk prostate cancer (PCa): Feasibility and comparison to 68Ga-Prostate Specific Membrane Antigen (PSMA)-PET\/CT","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.112033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112033"}}